发明名称 СПИРОСОЕДИНЕНИЯ, СОДЕРЖАЩИЕ ИХ ЛЕКАРСТВЕННЫЕ КОМПОЗИЦИИ И ПРОМЕЖУТОЧНЫЕ СОЕДИНЕНИЯ УКАЗАННЫХ СОЕДИНЕНИЙ
摘要 A spiro compound represented by the following formula (I) <CHEM> wherein R<1> and R<2> are the same or different and each is a hydrogen atom, a chlorine atom and the like, n is 1, 2 or 3, a bond containing a broken line is a single bond or a double bond, A is -X-(CH2)q-N(R<3>)(R<4>); a group represented by the following formula (a) <CHEM> and the like, wherein X is an oxygen atom or a sulfur atom, q is 2 or 3, R<3> and R<4> are the same or different and each is a C1-6 alkyl group and the like, or R<3> and R<4> optionally form, together with the adjacent nitrogen atom, a piperidine ring and the like optionally substituted by one or two C1-6 alkyl and the like, R<5> is a C1-6 alkyl group and the like, R<6> is a hydrogen atom and the like, and r and t are each independently one or two, or a pharmaceutically acceptable acid addition salt thereof. The compound is useful as a selective estrogen receptor modulator having a climacteric syndrome-ameliorating effect, and can be expected to be a drug for the prophylaxis and/or treatment of osteoporosis, climacteric syndrome and breast cancer.
申请公布号 RU2005113238(A) 申请公布日期 2006.01.20
申请号 RU20050113238 申请日期 2003.04.17
申请人 ДАЙНИППОН ФАРМАСЬЮТИКАЛ КО., ЛТД. (JP) 发明人 ВАТАНАБЕ Нобухиде (JP);НАКАГАВА Хироси (JP);ЦУДЗИ Дзун-ити (JP);МИНАТО Хисао (JP);ИКЕНО Акихиса (JP);КОХАЙАКАВА Тие (JP)
分类号 C07C217/18;A61K31/138;A61K31/40;A61K31/445;A61K31/4453;A61K31/451;A61K31/495;A61K31/55;A61P15/12;A61P19/10;A61P35/00;A61P43/00;C07C217/20;C07C217/24;C07D211/14;C07D295/092 主分类号 C07C217/18
代理机构 代理人
主权项
地址